Injective (INJ) Surges 15% Amid EVM Testnet Launch and Bullish Breakout

Terrill Dicki
Jul 12, 2025 07:50

Injective (INJ) surged 15% this week, breaking a multi-month bearish trend. With its EVM testnet launch, rising adoption, and bullish technical momentum, INJ eyes $15+.

1. Executive Summary

Injective (INJ) has captured the spotlight this week with a stellar 15.26% price surge, breaking out of a multi-month descending channel. Positive developments, including the launch of its Ethereum Virtual Machine (EVM) testnet and a 1,500% spike in daily active addresses since January, have bolstered bullish sentiment. Despite some broader market weakness earlier in the week, Injective’s strong fundamentals and technical breakout signal promising upside potential.

---

2. Recent Market Developments

The past week has been eventful for Injective, with several key developments driving price activity:

• July 12, 2025: INJ surged 15.26%, breaking out of its bearish structure with renewed bullish momentum. Key resistance zones at $14.16 and $15.43 are now in focus as positive funding rates suggest strong trader conviction.
• July 11, 2025: Injective joined the broader market rally, trading near $13 after breaking its descending channel. A successful retest of the trendline could pave the way for sustained upside.
• July 9, 2025: Injective launched its EVM testnet, positioning itself as a leader in real-world asset (RWA) tokenization. This milestone coincided with a nearly 10x increase in daily active addresses over the past six months.
• July 6, 2025: On-chain usage spiked 1,500% since January, driving a quarterly price surge of 46.78%, with INJ defending the $10 level after reaching $15 in May.

While INJ experienced minor declines earlier in the week due to broader market pressures, its strong recovery and ecosystem growth have reinforced optimism among investors.

---

3. Technical Analysis

Injective’s price dynamics reflect a cautiously bullish trend, supported by robust technical indicators:

• Current Price: $12.57
• 24h High/Low: $13.16 / $12.06
• Moving Averages:
  • Short-term (SMA7: $11.37, EMA12: $11.42) indicate bullish momentum.
  • Long-term resistance lies above the SMA_200 at $13.33.

• Momentum Indicators:
  • RSI(14): 60.22, signaling moderate bullish strength.
  • MACD: Positive at 0.0836, with a histogram value of 0.2454, suggesting growing upward momentum.

• Bollinger Bands: With the price above the upper band (%B: 1.0717), INJ may face overbought conditions short-term but remains bullish overall.
• Key Levels:
  • Resistance 1: $13.16 (24h high).
  • Resistance 2: $15.48.
  • Support 1: $9.43.

The trend remains weakly bullish, with a breakout above $13.33 likely confirming a stronger move toward $15.

---

4. Trading Strategy and Signals

• Short-Term Traders: Monitor $13.16 for a potential breakout. A retest of the $12.60 pivot level could offer attractive entry points.
• Swing Traders: Look for sustained momentum above $13.33 (SMA_200) to target $15.48.
• Risk Management: Protect downside with stop-loss orders near $11.50, just below the EMA_12.

---

5. Price Predictions and Outlook

With Injective’s bullish breakout and key ecosystem updates, the outlook appears favorable:

• Short-Term Target: $13.16–$15.48, contingent on maintaining funding rates and bullish momentum.
• Medium-Term Target: A sustained move above $15 could set the stage for $18–$20, especially if ecosystem adoption accelerates.

However, broader macroeconomic conditions and crypto market sentiment remain key variables.

---

6. Risk Analysis

While Injective shows strong potential, risks persist:

• Market Volatility: Broader crypto market pressures could limit gains, as seen in the July 9 decline.
• Overbought Conditions: Technical indicators like RSI and Bollinger Bands suggest the possibility of short-term pullbacks.
• Macro Sentiment: External factors, including regulatory developments, could impact INJ’s trajectory.

Investors should exercise caution, particularly if INJ fails to hold above $12.60.

---

7. Conclusion

Injective has emerged as a standout performer, driven by its EVM testnet launch, increased on-chain activity, and a decisive breakout from bearish trends. With technical indicators signaling bullish momentum, INJ is well-positioned to target $15 and beyond in the near term. However, traders should remain vigilant, balancing optimism with prudent risk management strategies.

Injective’s innovative ecosystem and recent achievements make it a project to watch in 2025.

Image source: Shutterstock